Bekker LG, Rebe K, Venter W, Maartens G, Moorhouse M, Conradie F, Wallis C, Black V, Harley B, Eakle R (2016). Southern African guidelines on the safe use of pre-exposure prophylaxi in persons at risk of the acquiring HIV-1 infection. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2016, 17 (1) pp. 1 - 11.
Berhanu R, Bistline K Schnippel, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I (2016). Early Outcomes of Decentralised Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLOS ONE, 2016, 11 (11) pp. 1 – 14.
Bistline KS, Berhanu R, Black A, Firnhaber C, Maitisa N, Evans D, Sinanovic E (2016). Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study. BMC INFECTIOUS DISEASES, 2016, 16 (1) pp. 1 - 10.
Bistline KS, Norbert N, Conradie F, Berhanu R, Claasen Z, Banoo S, Firnhaber C (2016). A call to action: Addressing the reproductive health needs of women with drug-resistant tuberculosis. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (4) pp. 333 - 334.
Blanchard K, Gutierrez H, Lince-Deroche N, Adanu R, Hill A (2016). Contraceptive use among Women in Accra, Ghana: 2003 and 2008. AFRICAN JOURNAL OF REPRODUCTIVE HEALTH, 2016, 20 (4) pp. 22 - 36.
Bohlius J, Maxwell N, Spoerri A, Wainwright R, Sawry S, Poole J, Eley B, Prozeskly H, Rabie H, Garona D, Technau K-G, Maskew M, Davies M, Davidson A, Stefan C, Egger M (2016). Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (6) pp. 164 - 170.
Brennan A, Bonawitz R, Bistline SK, Berhanu R, Maskew M, Long L, Bassett J Sanne I, Fox M (2016). Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (8) pp. 1040 - 1045.
Brennan A, Bonawitz R, Gill CJ, Thea DM, Kleinman M, Useem J, Garrison L, Ceccarelli R, Udokwu C, Long L, Fox M (2016). A meta-anaylsis assessing all-cause mortality in HV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS, 2016, 30 (15) pp. 2351 - 2360.
Brennan A, Long L, Useem J, Garrison L, Fox M (2016). Mortality in the First 3 Months on Antiretroviral THerapy Among HIV-Positive Adults in Low adn Middle Income Countries: A Meta Analysis JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (1) pp. 1 - 10.
Budgell E, Evans D, Bistline KS, Ive P, Long L, Rosen S (2016). Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (10) pp. 1002 - 1009.
Cassim N, Coetzee L-M, Bistline KS, Glencross D (2016). Compliance to HIV treatment monitoring guidelines can reduce laboratory costs. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2016, 17 (1) pp. 1 - 5.
Castillo-Mancilla JR, Aquilante CL, Wempe MF, Smeaton LM, Firnhaber C, LaRosa AM, Kurumasamy N, Andrade A, Baheti G, Fletcher CV, et al. E (2016). Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (6) pp. 1609 - 1618.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztein B, et al E, Panchia R, Sanne I (2016). Antiretroviral Therapy for the Prevention of HIV-1 Transmission. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (9) pp. 830 - 839.
De Waal R, Cohen K, Fox M, Stinson K, Maartens G, Boulle A, Davies M-A (2016). Clinician compliance with laboratory monitoring and prescribing guidelines in HIV 1-infected patients receiving tenofovir. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (4) pp. 369 - 371.
Diallo K , Kim A, Laher S, Ellenberger D, Beard RS, Dale H , Mackenzie H, Rivadeneira M, et al. et al., Carmona S, Macleod W Sherman G (2016). Early diagnosis of HIV infection in infants - one Caribbean and six Sub-Saharan African countries, 2011 – 2015. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (46) pp. 1285 - 1290.
Evans D, Berhanu R, Moyo F, Nguweneza A, Long L, Fox M (2016). Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antirtroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa. AIDS AND BEHAVIOR, 2016, 20 (5) pp. 2717 - 2728.
Firnhaber C, Goeieman B, Faesen M, Levin S, Williams S, Rameotshela S, Swarts A, Michelow P, Omar T, Williamson A, Allan B, Bistline KS, Smith J (2016). Prospective one year follow up of HIV infected women screened for cervical cancer using visual inspection with acetic acid, cytology and human papillomavirus testing in Johannesburg South Africa. PLOS ONE, 2016, 11 (1) pp. 1 - 11.
Fogel JM, Hudelson S, Ou S-S , Hart S, Wallis C , Morgado M, Saravanan S, Tripathy S, Hovind L, B-FS, Panchia R et al E (2016). HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (3) pp. 304 - 309.
Fox M, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D Mashamaite S, Sheik S, Jonker I, Howell P, Long L, Evans D (2016). Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (9) pp. 1131 - 1137.
Fox M, Rosen S, Geldsetzer P, Barnighausen T, Negussie E, Beanland R (2016). Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectiveness. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19 pp. 1 - 14.
Gajee R, Bistline KS, Mthupha N, Muzah B, Berhanu R (2016). Missed appointments among Rifampicin- resistant tuberculosis (RR-TB) patients at a decentralised RR-TB outpatient clinic in Johannesburg, South Africa. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (9) pp. 912 - 917.
Gama E, Madan J, Langley I, Girma M, Evans D, Rosen S, Squire SB (2016). Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM) protocol. BMJ OPEN, 2016, 6 pp. 1 - 7.
Gous N, Scott L, Potgieter J, Ntabeni L, Sanne I, Stevens W (2016). Implementation of Multiple Point-of-Care Testing in 2 HIV Antiretroviral Treatment Clinics in South Africa. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (2) pp. 34 - 43.
Grimsrud A, Cornell M, Schomaker M, Fox M, Orrell C, Prozesky H, Stinson K, Tanser F, Egger M, et al E (2016). CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2016, 70 pp. 549 - 555.
Hoffman S, Exner TM, Lince-Deroche N, Leu CS, Phillip JL, Kelvin EA, Gandhi AD, Levin B, Singh D, Mantell JE, Blanchard K, Ramjee G (2016). Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care. PLOS ONE, 2016, 11 (10) pp. 1 - 16.
Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, Kirui FK, Badal-Faesen S, Lagat D, Mohapi L, et al E (2016). Empirical Tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. LANCET, 2016, 387 pp. 1198 - 1209.
Jansen van Vuren P, Grobbelaar A, Storm N, Conteh O, Konneh K, Kamara A, Sanne I, Paweska J (2016). Comparative Evaluation of the Diagnostic Performance of the Prototype Cepheid GeneXpert Ebola Assay. JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (2) pp. 359 - 367.
Johnson LF, Chiu C, Myer L, Davies M-, Dorrington RE, Bekker L-Gl, Boulle A, Meyer-Rath G (2016). Prospects for HIV control in South Africa: a model-based analysis. GLOBAL HEALTH ACTION, 2016, 9 pp. 1 - 12.
Johnson LF, Keiser O, Fox M, Tanser F, Cornell M, Hoffmann C, Prozesky H, Boulle A, Davies MA (2016). Life expectancy trends in adults on antiretroviral treatment in South Africa. AIDS, 2016, 30 (16) pp. 2545 - 2550.
Katumba A, Reji E, Gitau T, Firnhaber C (2016). World Health Organisation staging, adherence to HAART and abnormal cervical smears amongst HIV-infected women attending a government hospital in Johannesburg, South Africa. SOUTHERN AFRICAN JOURNAL OF INFECTIOUS DISEASES (Formelry Southern African Journal of Epidemiology and Infection), 2016, 31 (4) pp. 112 - 118.
Larson B, Rockers PC, Bonawitz R, Sriruttan C, Glencross D, Cassim N, Coetzee LM, Greene GS, Chiller TM, Vallabhaneni S, Van Rensburg C, Long L, Govender N (2016). Screening HIV - Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa. PLOS ONE, 2016, 11 (7) pp. 1 - 23.
Lecher S, Williams J, Fonjungo PN, Kim AA, Zhang G, Toure CA, Agolory S, Appiah-Pippem G, et al. E, Carmona S, Macleod W, Stevens W (2016). Progress with Scale-up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015 - June 2016. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (47) pp. 1332 - 1335.
Long L, Fox M, Madondo C, Evans D, Sanne I, Rosen S (2016). The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa. PLOS ONE, 2016, 11 (2) pp. 1 - 12.
Long L, Rosen S, Brennan A, Moyo F, Madondo C, Evans D, Modi SL, Sanne I, Fox M (2016). Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic Versus a Hospital-Based HIV Clinic in South Africa. PLOS ONE, 2016, 11 (12) pp. 1 - 12.
Luetkemeyer AF., Firnhaber C, Kendall MA., Wu X, Mazurek GH, Benator DA., Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sanne I, et al E (2016). Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings. CLINICAL INFECTIOUS DISEASES, 2016, 62 (9) pp. 1081 - 1088.
Mahomed S, Behrens K, Slabbert M, Sanne I (2016). Managing human tissue transfer across national boundaries - an approach from an institution in South Africa. DEVELOPING WORLD BIOETHICS, 2016, 16 (1) pp. 28 - 35.
Maskew M, Fox M, Evans D, Govindasamy D, Jamieson L, Malete G, Mongwenyana C, Technau KG (2016). Insights into Adherence among a Cohort of Adolescents Aged 12-20 Years in South Africa: Reported Barriers to Antiretroviral Treatment. AIDS RESEARCH AND TREATMENT, 2016, 2016 pp. 1 - 12.
Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviera C, Hosseinipour M, Sugandhavesa P, et al. E, Mwelase N (2016). Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (2) pp. 123 - 129.
McLaren ZM, Bistline KS, Sharp A (2016). A data-driven evaluation of the stop TB global partnership strategy of targeting key populations at greater risk for tuberculosis. PLOS ONE, 2016, 11 (10) pp. 1 - 12.
McNamara L, Takuva S, Chirwa T, Macphail A (2016). Prevalence of common vitamin D receptor gene polymorphisms in HIV-infected and uninfected South Africans. INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS, 2016, 7 (1) pp. 74 - 80.
Michelow P, Sherrin A, Rossouw L, Mohaleamolla S, Evans D, Swarts A, Rakhombe N, Smith JS., Firnhaber C (2016). Performance of the Cellslide® automated liquid-based cytology system amongst HIV-positive women. AFRICAN JOURNAL OF LABORATORY MEDICINE, 2016, 5 (1) pp. 1 - 6.
Mokhele I, Evans D, Bistline KS, Swarts A, Smith JS, Firnhaber C (2016). Awareness, perceived risk and practices related to cervical cancer and Pap smar screening: A cross-sectional study among HIV-positive women attending an urban HIV clinic in Johannesburg, South Africa. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2016, 106 (12) pp. 1247 - 1253.
Moyo F, Chasela C, Brennan A, Ebrahim O, Sanne I, Long L, Evans D (2016). Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa. CLINICAL EPIDEMIOLOGY, 2016, 8 pp. 37 - 47.
Ncayiyana J, Bassett J, West N, Westreich D, Musenge E, Pettifor A, Emch M, Hanrahan CF, Schwartz S, Sanne I, Van RA (2016). Prevalence of latent turburculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study. BMC INFECTIOUS DISEASES, 2016, 16 pp. 1 - 10.
Onoya D, Brennan A, Berhanu R, van der Berg L, Buthelezi T, Fox M (2016). Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19 pp. 1 - 13.
Onoya D, Mohlabane N, Maduna V, van Zyl J, Sewpaul R, Naidoo Y (2016). Testing in the HIV Counselling and Testing (HCT) campaign, HIV risk behaviours and ART enrolment in South Africa. PUBLIC HEALTH, 2016, 136 pp. 152 - 160.
Pandie M, Wiesner L, McIlleron H, Hughes J, Siwendu S, Conradie F, Variava E, Maartens G (2016). Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 pp. 1037 - 1040.
Papasavvas E, Surrey LF, Glencross D, Azzoni L, Joseph J, Omar T, Feldman MD, Williamson AL, Siminya M, Swarts A, Yin X, Liu Q, Firnhaber C, Montaner L (2016). High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1 infected women. ONCOIMMUNOLOGY, 2016, 5 (5) pp. 1 - 12.
Platt MO, Evans D, Keegan PM, McNamara L, Parker E, Roberts L, Chaulk AM, Gleason RL, Seifu D, Amogne W, Penny C (2016). Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography. MOLECULAR BIOTECHNOLOGY, 2016, 58 pp. 56 - 64.
Pym A, Diacon A, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, Vasilyeva I, Andries K, Bakare N, et al E (2016). Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 pp. 394 - 402.
Robertson K, Jiang H, Evans SR , Marra CM, Berzins B, Hakim J, Sacktor N, Tulius SM, Campbell TB , Firnhaber C, Sanne I, et al. E (2016). International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. JOURNAL OF NEUROVIROLOGY, 2016, 22 pp. 472 - 478.
Rohr JK, Ive P, Horsburgh R, Berhanu R, Shearer KE, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox M (2016). Marginal Structural Models to Assess Delays in Secon-Line HIV Treatment Initiation in South Africa. PLOS ONE, 2016, 11 (8) pp. 1 - 11.
Rohr J, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox M (2016). Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19 pp. 1 - 9.
Rosen S, Fox M, Larson BA, Sow PS, Ehrenkranz PD, Venter W, Manabe YC, Kaplan J (2016). Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda. PLOS MEDICINE, 2016, 13 (8) pp. 1 - 13.
Rosen S, Maskew M, Fox M, Nyoni C, Mongwenyana C, Malete G, Sanne I, Bokaba D, Madondo C, Rohr J, Long L (2016). Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial. PLOS MEDICINE, 2016, 13 (5) pp. 1 - 19.
Saharia KK, Petrovas C, Ferrando-Martinez S, Leal M, Luque R, Ive P, Luetkemeyer A, Havlir D, Koup R (2016). Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. PLOS ONE, 2016, 11 (7) pp. 1 - 15.
Schwartz S, West N, Phofa R, Yende N, Sanne I, Bassett J, Van Rie A (2016). Acceptability and preferences for safer conception HIV prevention strategies: a qualitative study. INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (11) pp. 984 - 992.
Steegen K, Bronze M, Papathanasopoulos M, van Zyl G, Goedhals D, Van Vuuren C, Macleod W, Sanne I, Stevens W, Carmona S (2016). Prevalence of Antiretroviral Drug Resistance in Patients who are not responding to Protease Inhibitor-based Treatment: Results From the First National Survey in South Africa. JOURNAL OF INFECTIOUS DISEASES, 2016, 214 pp. 1826 - 1830.
Steegen K, Carmona S, Bronze M, Papathanasopoulos M, Van Zyl G, Goedhals D, Macleod W, Sanne I, Stevens W (2016). Moderate Levels of Pre-treatment HIV-1 Antiretroviral Drug Resistance Dectected in the First South African National Survey. PLOS ONE, 2016, 11 (12) pp. 1 - 12.
West N, Schwartz S, Phofa R, Yende N, Bassett J, Sanne I, Van Rie A (2016). "I don't know if this is right...but this is what I'm offering": healthcare provider knowledge, practice, and attitudes towards safer conception for HIV-affected couples in the context of Southern African guidelines. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2016, 28 (3) pp. 390 - 396.
